Human DDB2 splicing variants are dominant negative inhibitors of UV-damaged DNA repair

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Damaged DNA-binding protein (DDB) is crucial for repairing UV-induced DNA damage.
• DDB functions as a heterodimer composed of DDB1 and DDB2 proteins.

Purpose of the Study:

• Identify and characterize novel DDB2 variants generated by alternative splicing.
• Investigate the functional impact of these variants on DNA repair mechanisms.

Main Methods:

• Alternative splicing analysis in HeLa cells to identify DDB2 variants (D1-D4).
• RT-PCR for tissue distribution analysis.
• DNA repair assays to assess inhibitory effects.
• Electrophoresis mobility shift assays (EMSA) to study DNA-protein complex formation.
• Co-immunoprecipitation to analyze protein interactions.
• Transfection studies to evaluate nuclear import.

Main Results:

• Four DDB2 variants (D1-D4) were identified through alternative splicing.
• Variant D1 shows highest expression in human brain and heart tissues.
• Both D1 and D2 variants function as dominant negative inhibitors of DNA repair.
• D1 and D2 do not appear to be part of the damaged DNA-protein complex.
• DDB2-WT interacts with D1 and itself.
• Transfection with D1 results in reduced nuclear import of DDB1 compared to wild-type (WT).

Conclusions:

• DDB2 variants D1 and D2 act as dominant negative inhibitors of DNA repair.
• This inhibition is likely caused by disruption of DDB1-DDB2-WT complex formation.
• Impaired nuclear import of DDB1 also contributes to the inhibitory effect.